IN BRIEF: IQ-AI Says Development Of Stroke Diagnostic Product On Track

Mon, 27th Jul 2020 20:42

IQ-AI Ltd - medical software company - Subsidiary Imaging Biometrics technology noted that IB Stroke will first be made available as part of a streamlined workflow with IB Rad Tech and is on track and on target to be released early in fourth quarter.

Current stock price: 3.16 pence

Year-to-date change: down 22%

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Related Shares

More News

2 May 2024 15:45

EARNINGS AND TRADING: Trident Royalties swings to profit

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...

22 Feb 2024 14:02

IN BRIEF: IQ-AI shares sink on discounted placing fundraise

IQ-AI Ltd - Medical services firm and parent company of Wisconsin-based healthcare imaging software firm Imaging Biometrics LLC - Announces placing to...

9 Feb 2024 13:38

IQ-AI subsidiary asked by FDA to resubmit and modify application

(Alliance News) - IQ-AI Ltd on Friday said its subsidiary Imaging Biometric LLC will modify and resubmit its application to the US Food & Drug Adminis...

2 Feb 2024 08:56

IN BRIEF: IQ-AI celebrates USD100,000 grant for subsidiary

IQ-AI Ltd - St Helier, Jersey-based medical services firm - Says that Imaging Biometrics LLC, a wholly-owned subsidiary of IQ-AI, has been given a USD...

10 Jan 2024 11:48

IQ-AI falls after subsidiary notes launch of treatment access scheme

(Alliance News) - IQ-AI Ltd shares fell on Wednesday, after it said its subsidiary Imaging Biometrics LLC is launching an intermediate population coho...